Researchers from the University of Melbourne and Monash University have received $5.4 million from the Victorian government to establish the Victorian mRNA Innovation Hub (VMIH), to advance the technologies involved in mRNA vaccines and therapeutics production that proved pivotal in responding to the COVID-19 pandemic.
Read More
New chief commercialisation officer for Monash University
Dr Alastair Hick has been appointed to the new role of chief commercialisation officer at Monash University, overseeing Monash Innovation, the Generator, the equity portfolio through Monash Investment Holdings, and investment support for Monash start-ups.
Read More
Read More
Monash University opens new robotics research facility
The Monash University Faculty of Engineering has launched a new robotics research facility to train the next generation of engineers and global innovators and drive the emerging AI economy.
Read More
Read More
Monash ranked top university in the world for medical science
Monash University has been named as the world’s top university in Pharmacy and Pharmacology in the authoritative QS World University Rankings.
Read More
Read More
Government supports production of locally made medicine
Under the Modern Manufacturing Initiative, the federal government has announced $23 million in support for the Australian Precision Medicine Enterprise.
Read More
Read More
Monash University collaborates to make a net-zero liquid fuel
Researchers from Monash University and Hokkaido University have developed a method that converts carbon dioxide into a diesel-range fuel, with the potential to produce a net-zero liquid fuel alternative to power cars more sustainably.
Read More
Read More
Three new manufacturing hubs to be built at Monash University
A trio of projects at Monash University will be supported by the Victorian government under its Higher Education State Investment Fund to build a Medicines Manufacturing Innovation Centre (MMIC), a cancer therapy hub and a digital smart manufacturing space for start-ups.
Read More
Read More
FDA approves a new drug for the treatment of lupus in the US
This month, the US Food and Drug Administration (FDA) approved anifrolumab, a new drug developed for the treatment of lupus. This is the second drug approved for lupus in the past 60 years and until now, there’s been little specific treatment for the disease.
Read More
Read More
A 20-minute COVID-19 mass screening test co-developed at Monash
A Monash University Biomedicine Discovery Institute researcher, Dr Gavin Knott, has developed a CRISPR-based COVID-19 diagnostic test with other international scientists to detect results in 20 minutes, using a smartphone camera.
Read More
Read More
Monash University engineers strategies for a sustainable biomanufacturing industry
A Monash University PhD student in the Department of Chemical Engineering, Wei Jiang, has published a review of the potential and challenges of carbon compound biomanufacturing in Nature Chemical Biology, in efforts to find more sustainable processes for the manufacturing industry.
Read More
Read More
Johnson & Johnson Innovation Partnering Office produces more health solutions
The Johnson & Johnson Innovation Partnering Office collaboration – established by Monash University, Johnson & Johnson Innovation LLC and the Victorian government – has been extended. This will mean more novel healthcare solutions will be developed for commercialisation.
Read More
Read More
PowerPredict technology to forecast renewable energy generation
Monash University’s Grid Innovation Hub is collaborating with Palisade Energy and Worley, an engineering servicing company, to predict wind and solar power generation with machine learning technology, PowerPredict.
Read More
Read More
Adaptable oxygen conversion unit developed by Monash University
Researchers at Monash University have developed an oxygen conversion unit that can be built from local materials, which will enable doctors to provide life-saving oxygen treatment, particularly in India.
Read More
Read More
Tape-paper sensor test by Monash could detect jaundice in infants
Monash University researchers have developed a fast, cheap tape-paper sensor test to detect bilirubin in jaundiced newborns, which could be commercialised for point-of-care diagnosis of neonatal jaundice.
The joint
Read More
Read More
Total Artificial Heart to be commercialised by Monash and BiVACOR
A consortium of universities, hospitals and industry have received $1 million in federal government funding to develop and commercialise a durable Total Artificial Heart, led by Monash University
Read More
Read More
ENGIE and Monash to co-develop scalable Net Zero solutions
Monash University has signed a MOU with ENGIE, a global energy company, to potentially co-develop scalable zero-carbon solutions which accelerate implementation of Monash’s NetZero Initiative –
Read More
Read More
Monash University new surface on medical instruments reduces infection
Researchers at Monash University have engineered new antimicrobial surfaces that can reduce the number of bacteria which forms on medical instruments, like catheters, reducing the risk of patient
Read More
Read More
Construction industry gets automated at new Monash University facility
A research initiative to improve the quality and productivity of the construction industry using robotic technology has received more than half a million dollars from the Australian Research Council.
Professor
Read More
Read More
New tech extracts potential to identify quality graphene
Monash University engineers have developed world-first technology that can help industry identify and export high quality graphene cheaper, faster and more accurately.
Published in international journal
Read More
Read More
Monash student makes 3D printed key against viruses
A Monash University engineering student has used 3D printing to develop a plastic tool that can open doors and push buttons to slow the spread of viruses.
PhD student, Muthu Vellayappan, has created a
Read More
Read More